Medical Devices & Tech

Haemacure

215 Redfern Avenue Suite 100
Montreal, Quebec H3Z 3L5 Canada
Phone
Fax
Click for website

Research Sector Medical Devices & Tech

Summary Description Surgical devices, adhesives, and biomaterials for surgical wound care

Management Joseph Galli, Chairman of the Board and Chief Executive Officer; Marc Paquin, President and Director; Christian Hours, Ph.D., Vice President, Quality and Technical Affairs; Lyne Par?, CA, Director, Finance and Administration; Gilles Lemieux, B.Com., LL.L., Corporate Secretary, Investor Relations; Dawn Benson, Director of Quality Assurance and Quality Control

Click here for Financial Data
Keywords: wound, woundcare, Surgery Products, Surgery, hemostat, plasma proteins

Comment


Updated: May 01, 2013


Description

Haemacure Corporation is a specialty bio-therapeutics company developing high-value human biological adhesives, therapeutic proteins, and hemostats for commercialization. Haemacure's research and deve......view more

Products / Services

Haemacure's lead product candidate, Hemaseel(R) HMN, is a human-derived fibrin sealant in late-stage clinical development. Haemacure's second product candidate is a hemostat consisting of human thromb......view more

Technology / Differentiation

Haemacure's technologies utilize fibrinogen and thrombin from human plasma to arrest bleeding, seal tissues and act as an adjunct to wound healing. The synthesis of Haemacure products from human plasm...view more

Market / Customers

Haemacure's fibrin sealant and hemostats have numerous applications in the bio-surgical market, which is expected to grow at double-digit rates until 2015 to reach a U.S. market value of $1.5 billion.......view more


Status

Haemacure projects to have patients undergo surgery with its fibrin sealant as part of a clinical trial early in 2009. It will commercially launch its fibrin sealant in late 2010-early 2011....view more

RELATED COMPANIES



0000-00-00-5978